205 related articles for article (PubMed ID: 35578337)
1. Association of magnitude of weight loss and weight variability with mortality and major cardiovascular events among individuals with type 2 diabetes mellitus: a systematic review and meta-analysis.
Huang S; Shi K; Ren Y; Wang J; Yan WF; Qian WL; Yang ZG; Li Y
Cardiovasc Diabetol; 2022 May; 21(1):78. PubMed ID: 35578337
[TBL] [Abstract][Full Text] [Related]
2. Effects of glucagon-like peptide-1 receptor agonists on major cardiovascular events in patients with Type 2 diabetes mellitus with or without established cardiovascular disease: a meta-analysis of randomized controlled trials.
Marsico F; Paolillo S; Gargiulo P; Bruzzese D; Dell'Aversana S; Esposito I; Renga F; Esposito L; Marciano C; Dellegrottaglie S; Iesu I; Perrone Filardi P
Eur Heart J; 2020 Sep; 41(35):3346-3358. PubMed ID: 32077924
[TBL] [Abstract][Full Text] [Related]
3. Effect of intensive lifestyle intervention on the association between weight variability and major adverse cardiovascular events in overweight or obese adults with type 2 diabetes mellitus.
Zhong X; Xu X; Liu M; Wang P; He L; Christopher O; Zhang S; Lin Y; Huang Y; Xiong Z; Zhuang X; Liao X
J Diabetes Investig; 2023 Mar; 14(3):441-451. PubMed ID: 36597380
[TBL] [Abstract][Full Text] [Related]
4. Weight variability and cardiovascular outcomes: a systematic review and meta-analysis.
Massey RJ; Siddiqui MK; Pearson ER; Dawed AY
Cardiovasc Diabetol; 2023 Jan; 22(1):5. PubMed ID: 36624453
[TBL] [Abstract][Full Text] [Related]
5. Obesity and weight loss are inversely related to mortality and cardiovascular outcome in prediabetes and type 2 diabetes: data from the ORIGIN trial.
Doehner W; Gerstein HC; Ried J; Jung H; Asbrand C; Hess S; Anker SD
Eur Heart J; 2020 Jul; 41(28):2668-2677. PubMed ID: 32402060
[TBL] [Abstract][Full Text] [Related]
6. Association between weight change and incidence of cardiovascular disease events and mortality among adults with type 2 diabetes: a systematic review of observational studies and behavioural intervention trials.
Strelitz J; Lawlor ER; Wu Y; Estlin A; Nandakumar G; Ahern AL; Griffin SJ
Diabetologia; 2022 Mar; 65(3):424-439. PubMed ID: 34859263
[TBL] [Abstract][Full Text] [Related]
7. Comparison of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular outcomes in hypertensive patients with type 2 diabetes mellitus: A PRISMA-compliant systematic review and meta-analysis.
Lv X; Zhang Y; Niu Y; Song Q; Zhao Q
Medicine (Baltimore); 2018 Apr; 97(15):e0256. PubMed ID: 29642146
[TBL] [Abstract][Full Text] [Related]
8. Renal and Cardiovascular Outcomes After Weight Loss From Gastric Bypass Surgery in Type 2 Diabetes: Cardiorenal Risk Reductions Exceed Atherosclerotic Benefits.
Liakopoulos V; Franzén S; Svensson AM; Sattar N; Miftaraj M; Björck S; Ottosson J; Näslund I; Gudbjörnsdottir S; Eliasson B
Diabetes Care; 2020 Jun; 43(6):1276-1284. PubMed ID: 32152136
[TBL] [Abstract][Full Text] [Related]
9. Association of weight loss with cardiovascular or all-cause mortality in patients with heart failure: A meta-analysis.
Wu X; Wang Y; Hu X
Int J Obes (Lond); 2024 May; 48(5):626-634. PubMed ID: 38316960
[TBL] [Abstract][Full Text] [Related]
10. Retinopathy, Neuropathy, and Subsequent Cardiovascular Events in Patients with Type 2 Diabetes and Acute Coronary Syndrome in the ELIXA: The Importance of Disease Duration.
Seferovic JP; Bentley-Lewis R; Claggett B; Diaz R; Gerstein HC; Køber LV; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Pfeffer MA
J Diabetes Res; 2018; 2018():1631263. PubMed ID: 30648112
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular outcomes, heart failure and mortality in type 2 diabetic patients treated with glucagon-like peptide 1 receptor agonists (GLP-1 RAs): A systematic review and meta-analysis of observational cohort studies.
Herrera Comoglio R; Vidal Guitart X
Int J Clin Pract; 2020 Sep; 74(9):e13553. PubMed ID: 32452094
[TBL] [Abstract][Full Text] [Related]
12. The Risks of Cardiovascular Disease and Mortality Following Weight Change in Adults with Diabetes: Results from ADVANCE.
Lee AK; Woodward M; Wang D; Ohkuma T; Warren B; Sharrett AR; Williams B; Marre M; Hamet P; Harrap S; Mcevoy JW; Chalmers J; Selvin E
J Clin Endocrinol Metab; 2020 Jan; 105(1):152-62. PubMed ID: 31588504
[TBL] [Abstract][Full Text] [Related]
13. Diabetic retinopathy predicts all-cause mortality and cardiovascular events in both type 1 and 2 diabetes: meta-analysis of observational studies.
Kramer CK; Rodrigues TC; Canani LH; Gross JL; Azevedo MJ
Diabetes Care; 2011 May; 34(5):1238-44. PubMed ID: 21525504
[TBL] [Abstract][Full Text] [Related]
14. The Effects of SGLT2 Inhibitors on Cardiovascular and Renal Outcomes in Diabetic Patients: A Systematic Review and Meta-Analysis.
Lo KB; Gul F; Ram P; Kluger AY; Tecson KM; McCullough PA; Rangaswami J
Cardiorenal Med; 2020; 10(1):1-10. PubMed ID: 31743918
[TBL] [Abstract][Full Text] [Related]
15. Association between Body Mass Index and Mortality in Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis.
Jung HN; Kim S; Jung CH; Cho YK
J Obes Metab Syndr; 2023 Jun; 32(2):151-162. PubMed ID: 37280725
[TBL] [Abstract][Full Text] [Related]
16. Overweight, obesity and risk of all-cause and cardiovascular mortality in patients with type 2 diabetes mellitus: a dose-response meta-analysis of prospective cohort studies.
Liu XM; Liu YJ; Zhan J; He QQ
Eur J Epidemiol; 2015 Jan; 30(1):35-45. PubMed ID: 25421785
[TBL] [Abstract][Full Text] [Related]
17. Effects of glucose-lowering and multifactorial interventions on cardiovascular and mortality outcomes: a meta-analysis of randomized control trials.
Seidu S; Achana FA; Gray LJ; Davies MJ; Khunti K
Diabet Med; 2016 Mar; 33(3):280-9. PubMed ID: 26282461
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
